Disease Domain | Count |
---|---|
Infectious Diseases | 16 |
Nervous System Diseases | 2 |
Top 5 Drug Type | Count |
---|---|
Prophylactic vaccine | 15 |
Inactivated vaccine | 5 |
Vaccine | 2 |
Combination vaccine | 1 |
Genetically engineered subunit vaccine | 1 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date21 Feb 2023 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date29 Jan 2023 |
Target- |
Mechanism Immunostimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date08 Jun 2018 |
Start Date30 Jul 2024 |
Sponsor / Collaborator |
Start Date15 Dec 2021 |
Sponsor / Collaborator |
Start Date17 Nov 2021 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Meningococcal A/C vaccine(Hualan Biological Bacterin Co., Ltd.) | Encephalomyelitis More | Approved |
Influenza virus vaccine(Hualan Biological Bacterin Co., Ltd.) | Influenza, Human More | Approved |
Rabies Vaccine(Hualan Biological Bacterin) | Rabies More | Approved |
Tetravalent influenza split virion vaccine, inactivated (Hualan Biological) | Influenza, Human More | Approved |
Tetanus Vaccine,Adsorbed (Hualan Biological Bacterin ) | Tetanus More | Approved |